These novel therapies , Tirzepatide , represent a groundbreaking advancement in treating type 2 diabetes and potentially associated conditions . They all are classified as GLP-1 receptor agonists , https://heidiyzlz221833.dm-blog.com/41691901/tirzepatide-a-thorough-examination-into-glp-1-agents